83010-84-8 Usage
Uses
Used in Chemical Synthesis and Research:
7-Methoxy-8-quinolinamine is primarily used as a chemical intermediate in the synthesis of various organic compounds and pharmaceuticals. Its unique structure and properties make it a valuable component in the development of new chemical entities and materials.
However, there are no well-documented uses or effects of 7-Methoxy-8-quinolinamine on human health or the environment. This indicates the need for further studies to better understand the potential applications and impacts of this chemical compound. As research progresses, it is possible that new uses and applications for 7-Methoxy-8-quinolinamine may be discovered, expanding its utility in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 83010-84-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,0,1 and 0 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 83010-84:
(7*8)+(6*3)+(5*0)+(4*1)+(3*0)+(2*8)+(1*4)=98
98 % 10 = 8
So 83010-84-8 is a valid CAS Registry Number.
83010-84-8Relevant academic research and scientific papers
Use of a readily removable auxiliary group for the synthesis of pyrrolidones by the palladium-catalyzed intramolecular amination of unactivated γ C(sp3)-H Bonds
He, Gang,Zhang, Shu-Yu,Nack, William A.,Li, Qiong,Chen, Gong
, p. 11124 - 11128 (2013/10/22)
Easy on, easy off: Directing groups found to promote the palladium-catalyzed amination of γ C(sp3)-H and C(sp 2)-H bonds of secondary amides included 5-methoxy-8-aminoquinoline, which can be removed under mild conditions (see scheme; CAN=ceric ammonium nitrate). In conjunction with a β-C-H methylation or γ-C-H arylation step, the γ-C(sp3)-H amination provided access to complex pyrrolidones from readily available precursors. Copyright
Novel Sulfonaminoquinoline Hepcidin Antagonists
-
Page/Page column 130, (2012/09/05)
The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
